1 Min Read
Oct 6 (Reuters) - Uniqure NV:
* Uniqure announces FDA orphan drug designation for AMT-130 in huntington’s disease Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.